search

Management Team

Alistair MacdonaldChief Executive Officer
  • 20+ years’ experience in the pharmaceutical industry
  • Prior to the INC Research/inVentiv Health merger, served as CEO of INC Research since 2016, leading global operations, driving overall project delivery, implementation of new technologies, processes and solutions and their global expansion globally
  • Joined INC Research in 2002, and was responsible for full deployment of EDC, leading data management and building our global services teams
  • Has also served as our head of Global Business Development and Marketing, head of our Alliances Development and Delivery teams, head of Global Oncology, and president of Clinical Development Services
  • Has held management positions in the pharmaceutical industry across manufacturing, consultancy, business and corporate development, data management and clinical operations
  • MSc Environmental Diagnostics, Cranfield University; BSc (Hons) in Applied Geology, Plymouth Polytechnic; Diploma Qualification, UK Institute of Directors, 2015, Dip. Dir.
Mike BellExecutive Chairman of the Board of Directors and President, Commercial Division
  • Leads the Board of Directors and Commercial Division, designing valuable commercialization solutions; Business Lines include Selling Solutions, Communications, Medication Adherence (Patient Outcomes) and Consulting
  • Prior to the INC Research/inVentiv Health merger, served as CEO of inVentiv Health, bringing three decades of business management and operational expertise at leading global services companies
  • Previously served as Senior Executive Vice President, John Hancock Financial Services; Cofounder, Monitor Group, a consultancy providing strategic counsel to companies across the healthcare continuum; Managing Partner and Founder of Monitor Clipper Partners, a private equity firm specializing in healthcare outsourcing services
  • Extensive expertise in managing high-growth professional services firms; identifying strategic synergies and operational efficiencies; corporate transitions and turn-arounds; cultivating top talent
  • Bachelor's degree from The Wharton School at the University of Pennsylvania before attending Harvard Business School for a Master of Business Administration
Greg RushChief Financial Officer
  • Oversees financial operations globally, including Finance, Accounting, Tax, Treasury, Budgeting, and Financial Planning, as well as our Information Technology functions
  • Prior to the INC Research/ inVentiv Health merger, served as Chief Financial Officer at INC Research
  • Served as Senior Vice President and CFO of Tekelec, a leading high-tech solutions and service provider, from April 2010 to August 2013 and as Chief Accounting Officer of the company from May 2005 to March 2010
  • Has had repeated success in developing innovative financial management strategies, strong capital structures, high levels of operational support and sound corporate governance
  • Experience in private and public capital markets, completing more than 50 debt and equity financing transactions, including private equity transactions, initial public offerings (IPOs) and secondary offerings in the public markets
  • Bachelor of Science in Business and Master of Accounting (Honors) degrees from the University of North Carolina at Chapel Hill, U.S. and Certified Public Accountant (CPA)
Brandon EldredgeCorporate Strategy & Development
  • Responsible for strategy development and implementation, evaluating options for growth and M&A opportunities
  • Extensive expertise in corporate strategy; planning and execution; mergers; acquisitions; investments; joint ventures; alliances and partnerships
  • Prior to the INC Research/inVentiv Health merger, served as Senior Vice President, Corporate Strategy & Development at inVentiv Health
  • Previously worked with Barclays Capital in the Healthcare Investment Banking M&A division; also served as Director of Corporate Development at Thermo Fisher Scientific
  • Bachelor of Science degree from Babson College
Neil FergusonChief Business Officer
  • Responsible for a best-practice enterprise business development capability, developing knowledge, tools and processes to prospect new opportunities while continuing to delight our portfolio of small, mid-size and large biopharmaceutical customer
  • More than 25 years of experience in sales and operational roles in the CRO and biopharmaceutical industries
  • Prior to the INC Research/inVentiv Health merger, served as Chief Commercial Officer and Executive Vice President of Sales at INC Research
  • Previously worked at Quintiles for almost 15 years in a number of senior positions, including Vice President and Head of Commercial Sales for North America; Vice President of Commercial Operations for North America; Managing Director at Quintiles Greater China
  • Bachelor of Science in Applied Biological Sciences from the University of the West of England
Chris GaenzleChief Administrative Officer and General Counsel
  • Responsible for Legal, Human Resources, Corporate Quality, Corporate Services (Procurement and Facilities) and Operations Management (Trusted Process® and non-billable clinical support); also serves as the Executive Liaison to the Board of Directors
  • 20 years of private practice, corporate legal and operational experience, chiefly in the pharmaceutical, medical and clinical research industries
  • Prior to the INC Research/inVentiv Health merger, served as Chief Administrative Officer and General Counsel at INC Research
  • Previously Assistant General Counsel at Pfizer Inc., having progressively held other senior roles
  • Was also a partner at Hunton and Williams LLP, in Richmond, V.A. and New York, N.Y.
  • Bachelor of Arts from Colgate University and J.D. from Syracuse University; visiting student at Washington & Lee University School of Law and admitted to practice in New York and Virginia
Mike McKelveyPresident, Clinical Division
  • Leads the Clinical Division, ensuring the company continues to deliver on our Full Service, FSP and Hybrid models; also drives our therapeutic alignment, protecting and continuing the Trusted Process®
  • Nearly three decades of experience building successful global organizations in the pharmaceutical services, healthcare IT, life sciences, technology and global core laboratory industries
  • Prior to the INC Research/inVentiv Health merger, served as President of the inVentiv Health Clinical Division, leading a team of 6,500 professionals with deep therapeutic capabilities in Phase I-IV services
  • Previously Executive Vice President and Chief Operating Officer, Aptiv Solutions (acquired by ICON in 2014); former CEO, President and Board member of eResearchTechnology, Inc. (ERT) also led PAREXEL's Phase II-IV clinical operations for the Americas, as well as their global data management and global biostatistics groups
  • Ph.D. and M.A. in Business Economics from the Wharton School at the University of Pennsylvania and a Bachelor of Arts degree in Economics from Williams College
Kristen SpensieriCorporate Communications and Marketing
  • Leads marketing and internal and external communications, promoting and protecting the company’s brand reputation among key stakeholders and employees
  • Prior to the INC Research/inVentiv merger, served as Global Head of Corporate Communications & Marketing at inVentiv Health
  • 20+ years of experience in the field of healthcare communications; recognized as one of the industry’s leading experts in strategic planning, corporate positioning, corporate reputation and corporate social responsibility
  • Previously served as Managing Director of Chandler Chicco Companies (Corporate Practice – Brandtectonics); also served as Marketing Director and Executive Project Manager at Oxford Health Plans, where she led strategic marketing efforts and facilitated the repositioning of the organization that included the launch of the nation's first alternative medicine benefit plan
  • Bachelor of Arts degree from Wellesley College and a Master's in Public Health from Yale University School of Medicine
Rachel StahlerChief Information Officer
  • Guides the Company’s enterprise technology efforts, collaborating with the business to harvest actionable data insights and designing a go-forward infrastructure to support employee, client and marketplace demands
  • Prior to the INC Research/inVentiv merger, served as the Chief Information Officer for inVentiv Health; responsible for the company’s technology portfolio, partnering with colleagues in the Clinical and Commercial Divisions to create faster processes, better practices and smarter systems that help accelerate our clients’ success
  • Expertise in developing solutions that improve efficiencies and client service, and ultimately enable patient care solutions
  • Previously Chief Information Officer and Senior Vice President of Marketing, Optimer Pharmaceuticals; also held various senior technology roles at Pfizer, including Global Center of Excellence Lead
  • Bachelor of Arts degree from the University of Pennsylvania (Summa Cum Laude) and an MBA from Columbia Business School (Honors)
Jean ChitwoodAdvisor to the CEO Transition and Culture
  • Area of focus is on executing a seamless transition and harnessing the collective culture we’ll develop together
  • Prior to the INC Research and inVentiv Health merger, served as Executive Vice President, Corporate Strategy & Development at INC Research, where she initiated a change management capability to improve return on investment of business initiatives
  • More than 25 years of experience in healthcare with a variety of roles across academia, pharmaceutical and CRO sectors
  • Previous experience includes providing corporate positioning and leading business development and fundraising efforts for the start-up, Erimos Pharmaceuticals
  • Bachelor of Science in Medical Technology from Radford University; MBA from University of North Carolina, Kenan-Flagler Business School